Skip to main content
PMC home page
Springer logoLink to Springer
. 2022 Jan 21;39(3):1446. doi: 10.1007/s12325-021-02019-8

Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

Maggie Tabberer 1,✉, C Elaine Jones 2, Sally Kilbride 1, David M G Halpin 3, David A Lomas 4, Steven Pascoe 5, Dave Singh 6, Robert A Wise 7, Gerard J Criner 8, Peter Lange 9, Mark T Dransfield 10, MeiLan K Han 11, Fernando J Martinez 12, Morrys C Kaisermann 5, David A Lipson 5,13
PMCID: PMC9172769  PMID: 35060093

Correction to: Adv Ther (2020) 37:3775–3790 10.1007/s12325-020-01409-8

In the original article the disclosures for the author MeiLan K. Han are missing. MeiLan K. Han’s disclosures should read as “MeiLan K. Han has received personal fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Merck and Mylan. Research support was also received from Novartis and Sunovion”.

Articles from Advances in Therapy are provided here courtesy of Springer

RESOURCES